1. Home
  2. ADUS vs NVCR Comparison

ADUS vs NVCR Comparison

Compare ADUS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$93.00

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.62

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
NVCR
Founded
1979
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
ADUS
NVCR
Price
$93.00
$17.62
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$133.78
$28.08
AVG Volume (30 Days)
186.5K
1.3M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
23.40
21.79
EPS
1.36
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$9.17
$7.72
Revenue Next Year
$4.70
$6.74
P/E Ratio
$68.51
N/A
Revenue Growth
N/A
8.28
52 Week Low
$87.95
$9.82
52 Week High
$124.44
$18.92

Technical Indicators

Market Signals
Indicator
ADUS
NVCR
Relative Strength Index (RSI) 49.73 54.17
Support Level $89.99 $12.66
Resistance Level $96.54 $18.66
Average True Range (ATR) 2.55 1.04
MACD 0.30 -0.19
Stochastic Oscillator 55.36 61.57

Price Performance

Historical Comparison
ADUS
NVCR

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: